WFH Advocates for Hemophilia Care Access at WHO EMRO Meeting in Cairo
World Federation of Hemophilia / Fédération mondiale de l’hémophilie posted on LinkedIn:
”During the 72nd Session of the WHO Regional Committee for the Eastern Mediterranean in Cairo, Egypt, WFH Regional Manager Rana Saifi delivered a statement advocating for the inclusion of hemophilia and other Bleeding Disorders in the WHO EMRO flagship initiative to expand access to quality medical products in the region.
This aligns with the recent WHO 2025 Essential Medicines List updates, a critical step forward that requires concrete regional and national action to ensure access to lifesaving treatments.
Saifi also voiced WFH’s strong support for a WHA resolution on Global Action to Advance Health Equity for People with Hemophilia and Other Inherited Bleeding Disorders, proposed for discussion at the 158th session of the WHO Executive Board and backed by several Member States including Armenia, Morocco, with support from Egypt, Nepal and Sri Lanka.
Read the full statement here.”
Stay updated with Hemostasis Today.
-
Jun 5, 2026, 18:38Annie Bauzon: Clinical Significance and Causes of RBC Anisocytosis
-
Jun 5, 2026, 18:36Nandan Lad: Microclots as the Cause of Secondary Stroke After Subarachnoid Hemorrhage
-
Jun 5, 2026, 18:32George Sands: A Thoughtful Editorial on Low-Dose Rivaroxaban in Advanced CKD
-
Jun 5, 2026, 18:29Zain Khalpey: Recognizing High-Risk Coronary Hematoma Characteristics During PCI
-
Jun 5, 2026, 18:28Mirza Imail Baig: Silent but Significant – The Clinical Importance of Pulmonary Embolism
-
Jun 5, 2026, 17:26Anzila Waseem: Diet and Warfarin – A Guide to INR Stability
-
Jun 5, 2026, 17:06Lukas Mayer-Suess: How to Best Care for Patients Suffering Stroke Due to Isolated Cervical Internal Carotid Artery Occlusion
-
Jun 5, 2026, 17:02Sudhir Kumar: How Iron Deficiency Anemia Falsely Raises Diabetes Lab Results
-
Jun 5, 2026, 17:00Henning Nilius: An Explainable Machine Learning Tool for Pre-Surgery Screening